<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35544467</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>16</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>17</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1607-8454</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>27</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Hematology (Amsterdam, Netherlands)</Title>
          <ISOAbbreviation>Hematology</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Correlation of the transcription factors <i>IRF4</i> and <i>BACH2</i> with the abnormal <i>NFATC1</i> expression in T cells from chronic myeloid leukemia patients.</ArticleTitle>
        <Pagination>
          <StartPage>523</StartPage>
          <EndPage>529</EndPage>
          <MedlinePgn>523-529</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/16078454.2022.2066245</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">T cell dysfunction is a common characteristic of patients with myeloid leukemia and is closely related to clinical efficacy and prognosis. In order to clarify the mechanisms leading to the T cell dysfunction, we characterized the gene expression profile of T cells from chronic myelogenous leukemia (CML) patients by microarray analysis and investigated the related regulating pathway.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We employed gene expression profiling, bioinformatics and real-time quantitative reverse transcription PCR (RT-qPCR) to detect genes differentially expressed in CML patients versus healthy donors.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">There were 1704 genes differentially expressed between CD3<sup>+</sup> T cells from CML patients and healthy donors, including 868 up-regulated genes and 836 down-regulated genes, which mostly related to T cell functional pathways. In particular, lower expression of <i>NFATC1</i>, a member of the TCR signaling pathway, was detected in CD3<sup>+</sup> T cells from CML patients. We further found that the expression of <i>IRF4</i> and <i>BACH2</i>, transcription factors that potentially regulate <i>NFATC1</i>, in CD3<sup>+</sup> T cells from CML patients was significantly lower than that in healthy donors.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">We for the first time observed the altered gene expression profiles of CD3<sup>+</sup> T cells from CML patients, and the results suggested that <i>IRF4</i>, <i>BACH2</i> and <i>NFATC1</i> may be involved in regulating T cell dysfunction in CML patients in the form of a transcriptional regulatory network. These findings may provide potential targets for tyrosine kinase inhibitors in combination with other targeted immunotherapies .</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Yikai</ForeName>
            <Initials>Y</Initials>
            <Identifier Source="ORCID">0000-0002-6851-6260</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Hematology, First Affiliated Hospital, Institute of Hematology, School of Medicine, Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Guangzhou Municipality Tianhe Nuoya Bio-engineering Co. Ltd, Guangzhou, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zeng</LastName>
            <ForeName>Xiangbo</ForeName>
            <Initials>X</Initials>
            <Identifier Source="ORCID">0000-0002-3176-8800</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Hematology, First Affiliated Hospital, Institute of Hematology, School of Medicine, Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zha</LastName>
            <ForeName>Xianfeng</ForeName>
            <Initials>X</Initials>
            <Identifier Source="ORCID">0000-0002-4970-1305</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Laboratory, First Affiliated Hospital, Jinan University, Guangzhou, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lai</LastName>
            <ForeName>Jing</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0002-9581-7325</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Hematology, First Affiliated Hospital, Institute of Hematology, School of Medicine, Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tan</LastName>
            <ForeName>Guangxiao</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hematology, First Affiliated Hospital, Institute of Hematology, School of Medicine, Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Shaohua</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0003-4945-5914</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Hematology, First Affiliated Hospital, Institute of Hematology, School of Medicine, Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yu</LastName>
            <ForeName>Xibao</ForeName>
            <Initials>X</Initials>
            <Identifier Source="ORCID">0000-0003-0643-8372</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Hematology, First Affiliated Hospital, Institute of Hematology, School of Medicine, Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Yangqiu</ForeName>
            <Initials>Y</Initials>
            <Identifier Source="ORCID">0000-0002-0974-4036</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Hematology, First Affiliated Hospital, Institute of Hematology, School of Medicine, Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Ling</ForeName>
            <Initials>L</Initials>
            <Identifier Source="ORCID">0000-0002-7044-7663</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Hematology, First Affiliated Hospital, Institute of Hematology, School of Medicine, Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Hematology</MedlineTA>
        <NlmUniqueID>9708388</NlmUniqueID>
        <ISSNLinking>1024-5332</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C491123">BACH2 protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D050976">Basic-Leucine Zipper Transcription Factors</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D050835">Interferon Regulatory Factors</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D050778">NFATC Transcription Factors</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C494003">NFATC1 protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C094531">interferon regulatory factor-4</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D050976" MajorTopicYN="N">Basic-Leucine Zipper Transcription Factors</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D050835" MajorTopicYN="N">Interferon Regulatory Factors</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015464" MajorTopicYN="Y">Leukemia, Myelogenous, Chronic, BCR-ABL Positive</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007951" MajorTopicYN="Y">Leukemia, Myeloid</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018655" MajorTopicYN="N">Lymphocyte Count</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D050778" MajorTopicYN="N">NFATC Transcription Factors</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013601" MajorTopicYN="N">T-Lymphocytes</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">BACH2</Keyword>
        <Keyword MajorTopicYN="N">CML</Keyword>
        <Keyword MajorTopicYN="N">IRF4</Keyword>
        <Keyword MajorTopicYN="N">NFATC1</Keyword>
        <Keyword MajorTopicYN="N">T cell</Keyword>
        <Keyword MajorTopicYN="N">T cell dysfunction</Keyword>
        <Keyword MajorTopicYN="N">immunotherapy</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>11</Day>
          <Hour>13</Hour>
          <Minute>42</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35544467</ArticleId>
        <ArticleId IdType="doi">10.1080/16078454.2022.2066245</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
